KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Invested Capital (2017 - 2025)

Teva Pharmaceutical Industries' Return on Invested Capital history spans 9 years, with the latest figure at 0.29% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital rose 35.0% year-over-year to 0.29%, compared with a TTM value of 0.29% through Dec 2025, up 35.0%, and an annual FY2025 reading of 0.29%, up 35.0% over the prior year.
  • Return on Invested Capital for Q4 2025 was 0.29% at Teva Pharmaceutical Industries, up from 0.18% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.48% in Q2 2024, with the low at 0.24% in Q1 2021.
  • Average Return on Invested Capital over 5 years is 0.03%, with a median of 0.03% recorded in 2024.
  • Year-over-year, Return on Invested Capital fell -24bps in 2022 and then soared 62bps in 2024.
  • Tracing TEVA's Return on Invested Capital over 5 years: stood at 0.09% in 2021, then tumbled by -275bps to 0.15% in 2022, then skyrocketed by 130bps to 0.05% in 2023, then crashed by -225bps to 0.06% in 2024, then skyrocketed by 607bps to 0.29% in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Return on Invested Capital are 0.29% (Q4 2025), 0.18% (Q3 2025), and 0.29% (Q2 2025).